Format

Send to

Choose Destination
Phytother Res. 2019 Jun;33(6):1604-1615. doi: 10.1002/ptr.6349. Epub 2019 Apr 21.

Therapeutic efficacy and safety of chamomile for state anxiety, generalized anxiety disorder, insomnia, and sleep quality: A systematic review and meta-analysis of randomized trials and quasi-randomized trials.

Author information

1
Faculty of Medicine, University of Medicine of Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
2
Online Research Club (http://www.onlineresearchclub.org), Nagasaki, Japan.
3
Sulaiman Al Rajhi Colleges, College of Medicine, Qassim, Saudi Arabia.
4
Kubutambahan II Public Health Center, Singaraja, 81172, Indonesia.
5
Faculty of Medicine, Mansoura University, Mansoura, Egypt.
6
Department of General Medicine, Nishtar Medical University, Multan, Punjab, Pakistan.
7
Faculty of Medicine, Alexandria University, Alexandria, Egypt.
8
Faculty of Medicine, Damascus University, Damascus, Syria.
9
Faculty of Medicine, Vo Truong Toan University, Hau Giang, Vietnam.
10
Department of Immunogenetics, Institute of Tropical Medicine (NEKKEN), Leading Graduate School Program, and Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, 852-8523, Japan.
11
Evidence Based Medicine Research Group, Ton Duc Thang University, Ho Chi Minh City, 70000, Vietnam.
12
Faculty of Applied Sciences, Ton Duc Thang University, Ho Chi Minh City, 70000, Vietnam.
13
Department of Clinical Product Development, Institute of Tropical Medicine (NEKKEN), School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, 852-8523, Japan.

Abstract

This systematic review and meta-analysis aimed to study the efficacy and safety of chamomile for the treatment of state anxiety, generalized anxiety disorders (GADs), sleep quality, and insomnia in human. Eleven databases including PubMed, Science Direct, Cochrane Central, and Scopus were searched to retrieve relevant randomized control trials (RCTs), and 12 RCTs were included. Random effect meta-analysis was performed by meta package of R statistical software version 3.4.3 and RevMan version 5.3. Our meta-analysis of three RCTs did not show any difference in case of anxiety (standardized mean difference = -0.15, 95% CI [-0.46, 0.16], P = 0.4214). Moreover, there is only one RCT that evaluated the effect of chamomile on insomnia and it found no significant change in insomnia severity index (P > 0.05). By using HAM-A scale, there was a significant improvement in GAD after 2 and 4 weeks of treatment (mean difference = -1.43, 95% CI [-2.47, -0.39], P = 0.007), (MD = -1.79, 95% CI [-3.14, -0.43], P = 0.0097), respectively. Noteworthy, our meta-analysis showed a significant improvement in sleep quality after chamomile administration (standardized mean difference = -0.73, 95% CI [-1.23, -0.23], P < 0.005). Mild adverse events were only reported by three RCTs. Chamomile appears to be efficacious and safe for sleep quality and GAD. Little evidence is there to show its effect on anxiety and insomnia. Larger RCTs are needed to ascertain these findings.

KEYWORDS:

GAD; chamomile; generalized anxiety disorders; insomnia; sleep quality; state anxiety

PMID:
31006899
DOI:
10.1002/ptr.6349

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center